SPRY4 and cancer: The meta-analysis results showed that the HR of association between increased SPRY4-IT1 expression level and DFS in these cancer patients was 3.03 (95% CI: 2.51-3.65), and I2= 97% and Ph<0.001, suggesting that there is great heterogeneity existing between these studies (Figure 8).